<VariationArchive VariationID="377381" VariationName="NG_008852.1:g.[135909G&gt;T;8170_32961del24792]" VariationType="Haplotype" Accession="VCV000377381" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-05-08" DateCreated="2017-08-07" MostRecentSubmission="2017-08-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <Haplotype VariationID="377381" NumberOfChromosomes="1">
      <SimpleAllele AlleleID="364266" VariationID="393289">
        <GeneList>
          <Gene Symbol="INSR" FullName="insulin receptor" GeneID="3643" HGNC_ID="HGNC:6091" Source="submitted" RelationshipType="within single gene">
            <Location>
              <CytogeneticLocation>19p13.2</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="7112265" stop="7294414" display_start="7112265" display_stop="7294414" Strand="-" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="7112265" stop="7294010" display_start="7112265" display_stop="7294010" Strand="-" />
            </Location>
            <OMIM>147670</OMIM>
          </Gene>
        </GeneList>
        <Name>NG_008852.1:g.8170_32961del24792</Name>
        <VariantType>Deletion</VariantType>
        <Location>
          <CytogeneticLocation>19p13.2</CytogeneticLocation>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="7266040" stop="7290831" display_start="7266040" display_stop="7290831" variantLength="24792" />
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="7266051" stop="7290842" display_start="7266051" display_stop="7290842" variantLength="24792" />
        </Location>
        <HGVSlist>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.7266040_7290831del" Assembly="GRCh38">
              <Expression>NC_000019.10:g.7266040_7290831del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.7266051_7290842del" Assembly="GRCh37">
              <Expression>NC_000019.9:g.7266051_7290842del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_008852.1" sequenceAccession="NG_008852" sequenceVersion="1" change="g.8170_32961del24792">
              <Expression>NG_008852.1:g.8170_32961del24792</Expression>
            </NucleotideExpression>
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification NumberOfSubmissions="0" NumberOfSubmitters="0">
            <ReviewStatus>no classification for the single variant</ReviewStatus>
            <Description>no classification for the single variant</Description>
          </GermlineClassification>
          <SomaticClinicalImpact NumberOfSubmissions="0" NumberOfSubmitters="0">
            <ReviewStatus>no classification for the single variant</ReviewStatus>
            <Description>no classification for the single variant</Description>
          </SomaticClinicalImpact>
          <OncogenicityClassification NumberOfSubmissions="0" NumberOfSubmitters="0">
            <ReviewStatus>no classification for the single variant</ReviewStatus>
            <Description>no classification for the single variant</Description>
          </OncogenicityClassification>
        </Classifications>
        <XRefList>
          <XRef Type="Interpreted" ID="377381" DB="ClinVar" />
        </XRefList>
      </SimpleAllele>
      <SimpleAllele AlleleID="364263" VariationID="393292">
        <GeneList>
          <Gene Symbol="INSR" FullName="insulin receptor" GeneID="3643" HGNC_ID="HGNC:6091" Source="submitted" RelationshipType="within single gene">
            <Location>
              <CytogeneticLocation>19p13.2</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="7112265" stop="7294414" display_start="7112265" display_stop="7294414" Strand="-" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="7112265" stop="7294010" display_start="7112265" display_stop="7294010" Strand="-" />
            </Location>
            <OMIM>147670</OMIM>
          </Gene>
        </GeneList>
        <Name>NM_000208.4(INSR):c.1969G&gt;T (p.Val657Phe)</Name>
        <CanonicalSPDI>NC_000019.10:7163091:C:A</CanonicalSPDI>
        <VariantType>single nucleotide variant</VariantType>
        <Location>
          <CytogeneticLocation>19p13.2</CytogeneticLocation>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="7163092" stop="7163092" display_start="7163092" display_stop="7163092" variantLength="1" positionVCF="7163092" referenceAlleleVCF="C" alternateAlleleVCF="A" />
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="7163103" stop="7163103" display_start="7163103" display_stop="7163103" variantLength="1" positionVCF="7163103" referenceAlleleVCF="C" alternateAlleleVCF="A" />
        </Location>
        <ProteinChange>V657F</ProteinChange>
        <HGVSlist>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.7163092C&gt;A" Assembly="GRCh38">
              <Expression>NC_000019.10:g.7163092C&gt;A</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.7163103C&gt;A" Assembly="GRCh37">
              <Expression>NC_000019.9:g.7163103C&gt;A</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_008852.2" sequenceAccession="NG_008852" sequenceVersion="2" change="g.135909G&gt;T">
              <Expression>NG_008852.2:g.135909G&gt;T</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_000208.4" sequenceAccession="NM_000208" sequenceVersion="4" change="c.1969G&gt;T" MANESelect="true">
              <Expression>NM_000208.4:c.1969G&gt;T</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_000199.2" sequenceAccession="NP_000199" sequenceVersion="2" change="p.Val657Phe">
              <Expression>NP_000199.2:p.Val657Phe</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001079817.3" sequenceAccession="NM_001079817" sequenceVersion="3" change="c.1969G&gt;T">
              <Expression>NM_001079817.3:c.1969G&gt;T</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001073285.1" sequenceAccession="NP_001073285" sequenceVersion="1" change="p.Val657Phe">
              <Expression>NP_001073285.1:p.Val657Phe</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification NumberOfSubmissions="0" NumberOfSubmitters="0">
            <ReviewStatus>no classification for the single variant</ReviewStatus>
            <Description>no classification for the single variant</Description>
          </GermlineClassification>
          <SomaticClinicalImpact NumberOfSubmissions="0" NumberOfSubmitters="0">
            <ReviewStatus>no classification for the single variant</ReviewStatus>
            <Description>no classification for the single variant</Description>
          </SomaticClinicalImpact>
          <OncogenicityClassification NumberOfSubmissions="0" NumberOfSubmitters="0">
            <ReviewStatus>no classification for the single variant</ReviewStatus>
            <Description>no classification for the single variant</Description>
          </OncogenicityClassification>
        </Classifications>
        <XRefList>
          <XRef Type="rs" ID="1135401737" DB="dbSNP" />
          <XRef Type="Interpreted" ID="377381" DB="ClinVar" />
        </XRefList>
      </SimpleAllele>
      <Name>NG_008852.1:g.[135909G&gt;T;8170_32961del24792]</Name>
      <VariationType>Haplotype</VariationType>
      <OtherNameList>
        <Name>[p.Val657Phe;p.Val34_Lys217del]</Name>
      </OtherNameList>
    </Haplotype>
    <RCVList>
      <RCVAccession Title="NG_008852.1:g.[135909G&gt;T;8170_32961del24792] AND Leprechaunism syndrome" Accession="RCV000496605" Version="3">
        <ClassifiedConditionList TraitSetID="4059">
          <ClassifiedCondition DB="MedGen" ID="C0265344">Leprechaunism syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2014-06-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2014-06-02" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-08-07" MostRecentSubmission="2017-08-07">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">28765322</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="4059" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4966" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Leprechaunism syndrome</ElementValue>
                <XRef ID="Leprechaunism+syndrome/8731" DB="Genetic Alliance" />
                <XRef ID="111307005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leprechaunism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Donohue syndrome</ElementValue>
                <XRef ID="MONDO:0009517" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">INSR-related severe syndromic insulin resistance comprises a phenotypic spectrum that is a continuum from the severe phenotype Donohue syndrome (DS) (also known as leprechaunism) to the milder phenotype Rabson-Mendenhall syndrome (RMS). DS at the severe end of the spectrum is characterized by severe insulin resistance (hyperinsulinemia with associated fasting hypoglycemia and postprandial hyperglycemia), severe prenatal growth restriction and postnatal growth failure, hypotonia and developmental delay, characteristic facies, and organomegaly involving heart, kidneys, liver, spleen, and ovaries. Death usually occurs before age one year. RMS at the milder end of the spectrum is characterized by severe insulin resistance that, although not as severe as that of DS, is nonetheless accompanied by fluctuations in blood glucose levels, diabetic ketoacidosis, and – in the second decade – microvascular complications. Findings can range from severe growth delay and intellectual disability to normal growth and development. Facial features can be milder than those of DS. Complications of longstanding hyperglycemia are the most common cause of death. While death usually occurs in the second decade, some affected individuals live longer.</Attribute>
                <XRef ID="NBK476444" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">INSR-Related Severe Syndromic Insulin Resistance</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6885" />
                <XRef ID="6885" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29369573</ID>
                <ID Source="BookShelf">NBK476444</ID>
              </Citation>
              <XRef ID="508" DB="Orphanet" />
              <XRef ID="C0265344" DB="MedGen" />
              <XRef ID="MONDO:0009517" DB="MONDO" />
              <XRef Type="MIM" ID="246200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="977160" SubmissionDate="2016-12-19" DateLastUpdated="2017-08-07" DateCreated="2017-08-07">
        <ClinVarSubmissionID localKey="NG_008852.1:g.[135909G&gt;T;8170_32961del24792]|OMIM:246200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000503034" DateUpdated="2017-08-07" DateCreated="2017-08-07" Type="SCV" Version="1" SubmitterName="Medical Research Institute, Tokyo Medical and Dental University" OrgID="505721" OrganizationCategory="other" OrgAbbreviation="TMDU_MRI" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506114" SubmitterName="Division of Diabetes and Metabolic Diseases, Graduate School of Medicine, University of Tokyo" Type="secondary" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-06-02">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">28765322</ID>
          </Citation>
          <Comment>Patient, a 1 year-old boy, showed acanthosis nigricans, hypertrichosis, and dysmorphic features, including elfin features and reduced subcutaneous adipose tissue stores. He showed hyperglycemia and hyperinsulinemia. And he had severe insulin resistance. This mutaion was confirmed compound heterozygosity.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Japanese</Ethnicity>
              <GeographicOrigin>Japan</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <Haplotype>
          <SimpleAllele>
            <GeneList>
              <Gene Symbol="INSR" />
            </GeneList>
            <VariantType>Variation</VariantType>
            <Location>
              <GeneLocation>NM_000208.2:exon 9;NM_000208.2:intron 1, exon 2 and intron 2</GeneLocation>
            </Location>
            <AttributeSet>
              <Attribute Type="HGVS">NG_008852.1:g.135909G&gt;T</Attribute>
            </AttributeSet>
          </SimpleAllele>
          <SimpleAllele>
            <GeneList>
              <Gene Symbol="INSR" />
            </GeneList>
            <VariantType>Variation</VariantType>
            <Location>
              <GeneLocation>NM_000208.2:exon 9;NM_000208.2:intron 1, exon 2 and intron 2</GeneLocation>
            </Location>
            <AttributeSet>
              <Attribute Type="HGVS">NG_008852.1:g.8170_32961del24792</Attribute>
            </AttributeSet>
          </SimpleAllele>
          <Name>NG_008852.1:g.[135909G&gt;T;8170_32961del24792]</Name>
          <OtherNameList>
            <Name>[p.Val657Phe;p.Val34_Lys217del]</Name>
          </OtherNameList>
        </Haplotype>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="246200" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28765322</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28765322</ID>
        </Citation>
        <Comment>Sanger sequencing.</Comment>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="977160" TraitType="Disease" MappingType="XRef" MappingValue="246200" MappingRef="OMIM">
        <MedGen CUI="C0265344" Name="Leprechaunism syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

